A new MMWR report outlines recommendations for the Johnson & Johnson (J&J) COVID-19 Vaccine from the Advisory Committee on Immunization Practices (ACIP). After a thorough safety review, ACIP reaffirmed its
recommended use of the J&J vaccine in all people 18 years and older, determining that the vaccine’s known and potential benefits outweigh its known and potential risks.Read the full report: bit.ly/MMWR42721.